Search - tctmd.com

Displaying 641 - 660 of 1856

Sort: Relevancy | Date

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

June 22, 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

June 21, 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

News Daily News

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

Yael L. Maxwell

June 20, 2018

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

June 12, 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

May 25, 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

May 24, 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

May 23, 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

News CV Team Pro

Featured Cath Lab Pro: Marian Hawkey

May 20, 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

May 17, 2018

Shivanshu Madan, MD

News Featured Fellow

Shivanshu Madan, MD

Yael L. Maxwell

May 14, 2018

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

May 11, 2018

News Industry News

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

May 02, 2018

TCTMD’s Top 10 Most Popular Stories for April 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

April 30, 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

April 28, 2018

Longer Hospital Stays After TAVR Associated With Worse Outcomes

News Conference News SCAI 2018

Longer Hospital Stays After TAVR Associated With Worse Outcomes

April 27, 2018

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

News Conference News SCAI 2018

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

April 26, 2018

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.